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We established several rules for including plans and beneficiaries in the study. Plans whose average pharmaceutical and medical utilization were significantly lower than the entire sample's plan-level averages were excluded to ensure that we had complete utilization data for our subjects. We also excluded plans with enrollment of fewer than 1000 members to ensure ample variation in individual characteristics within plans. We examined only primary beneficiaries and excluded dependents to maximize the likelihood that our plans would be the main source of prescription drug insurance coverage for the study population. To ensure that a patient's course of drug therapy could be tracked longitudinally, we considered only plans with at least 2 consecutive years of data, and only patients who were enrolled continuously in each year were eligible. OOP Index p = d ∈D copay p d N eFigure 2. Equation used to calculate the out-of-pocket (OOP) index to measure plan generosity. To capture plan generosity with a single variable, we developed an index that simulated the average annual OOP expenses that members of a standard sample would have paid had they faced the cost-sharing requirements and restrictions of each plan. To create the standard sample, we randomly sampled 100 people from each plan year and pooled their drug claims creating a "market basket" of drugs. Each drug claim in the market basket was standardized into 30-day supply equivalents. Thus, a 90-day mail-order claim was converted to three 30-day claims. A plan's average OOP cost for a 30-day supply of each drug was calculated and assigned to each corresponding 30-day drug claim in the market basket. Total costs were calculated for each individual (person-year), and the average total cost across individuals computed as the plan's OOP index value. Formally, D represents the universe of drug claims in the market basket; d, a specific 30-day equivalent drug claim in the market basket; p, a plan in a given year; N, the number of persons in the standard sample; and copay p d , the average OOP payment for drug d in plan year p.
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